ADAMTS-17 Inhibitors
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IKK-2 Inhibitor IV | 507475-17-4 | sc-203083 | 500 µg | $133.00 | 12 | |
TPCA-1 is a potent ADAMTS-6 inhibitor that works by blocking the enzymatic activity of ADAMTS-6, preventing it from cleaving its substrates, particularly aggrecan in cartilage. | ||||||
ARP 100 | 704888-90-4 | sc-203522 | 5 mg | $208.00 | 26 | |
ARP100 is a small molecule inhibitor of ADAMTS-6 that suppresses its enzymatic activity. | ||||||
Batimastat | 130370-60-4 | sc-203833 sc-203833A | 1 mg 10 mg | $179.00 $377.00 | 24 | |
Another broad-spectrum MMP inhibitor with activity against ADAMTS metalloproteinases. | ||||||
KU 0063794 | 938440-64-3 | sc-361219 | 10 mg | $209.00 | ||
INCB3344 is an inhibitor of ADAMTS-6, which could be utilized to reduce aggrecan degradation in cartilage and potentially mitigate the progression of osteoarthritis. | ||||||
2-Dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl | 564483-18-7 | sc-251742 sc-251742A | 1 g 5 g | $63.00 $236.00 | ||
UK-370106 is a compound that inhibits ADAMTS-6 by binding to its catalytic domain, impeding its ability to cleave aggrecan and other substrates in cartilage. | ||||||
MMP-2 Inhibitor II | 869577-51-5 | sc-354092 | 5 mg | $245.00 | ||
While primarily targeting MMP-2, it also shows inhibitory effects on some ADAMTS family members. | ||||||
WAY 170523 | 307002-73-9 | sc-361402 sc-361402A | 1 mg 10 mg | $275.00 $595.00 | 1 | |
A potent and selective inhibitor of ADAMTS-5, which is involved in the degradation of aggrecan in cartilage. | ||||||
TAPI-1 | 171235-71-5 | sc-222337 | 1 mg | $669.00 | 15 | |
These are hydroxamic acid-based inhibitors that target a range of metalloproteinases, including some ADAMTS family members. They function by binding to the active site of the enzymes. | ||||||
SB-3CT | 292605-14-2 | sc-205847 sc-205847A | 1 mg 5 mg | $102.00 $388.00 | 15 | |
Primarily known as an inhibitor of matrix metalloproteinases 2 and 9, SB-3CT has also shown activity against some ADAMTS enzymes. Its inhibition mechanism involves the chelation of the catalytic zinc ion. | ||||||